M1228 HCPCS code: Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test

M1228 is the HCPCS Level II code for patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case.

Code details

FieldValue
SectionM codes — Medical services and quality measures
Coverage codeC — Carrier judgment
Pricing indicator00 — Not separately priced by Medicare
BETOS categoryZ2
Added2024-01-01
Last action effective2024-01-01

What changed for M1228

Frequently asked questions

What is HCPCS code M1228?

M1228 is the HCPCS Level II code for patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test. Short descriptor: "Pt + hcv aby +vir w/ rx 3 mo".

Does Medicare cover M1228?

Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.

Related M12 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.

All M codes · HCPCS lookup